5 A Phase 1b, Open-Label, Safety, Tolerability, and Efficacy Study of HC-7366 in Combination with Belzutifan (WELIREGTM) in Patients with Advanced or Metastatic Renal Cell Carcinoma, NCT06234605

McKay, Rana R ; Garmezy, Ben ; Barata, Pedro ; Ornstein, Moshe ; Shah, Neil J ; Hammers, Hans ; Hutson, Thomas E ; Chisamore, Michael ; Karim, Dhamina ; Mattson, Paulette ; Lightcap, Eric ; Drees, Jeremy ; Harrison, Ben ; Holm, Megan ; Bose, Nandita ; Thomas, Cherry T ; Motzer, Robert J

The oncologist (Dayton, Ohio), 2024-08, Vol.29 (Supplement_1), p.S13-S13 [Periódico revisado por pares]

US: Oxford University Press

Texto completo disponível